SKI Market

A+| A| A-|

Indian Indices

Sensex

77,571.74 940.09
( 1.23%)

Global Indices

Nasdaq

48,208.69 277.76
(0.58%)

Dow Jones

6,845.97 42.16
(0.62%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,579.52 -29.36
(-0.28%)

Forex

USD-INR

92.44 -0.46
(-0.50%)

EUR-INR

107.96 0.52
(0.48%)

GBP-INR

124.05 0.88
(0.72%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

51.1335451

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

54.28

186.23

EPS(TTM)

Face Value()

Div & Yield %

1.21

Back

Fynx Capital reports standalone net loss of Rs 0.67 crore in the September 2025 quarter

Nov 08,2025

Net Loss of Fynx Capital reported to Rs 0.67 crore in the quarter ended September 2025 as against net loss of Rs 0.43 crore during the previous quarter ended September 2024. Sales reported to Rs 0.86 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.86	0	0
OPM %	-72.09	0	-
PBDT	-0.62	-0.33	-88
PBT	-0.69	-0.42	-64
NP	-0.67	-0.43	-56

77,571.74 940.09 ( 1.23%)

48,208.69 277.76 (0.58%)

6,845.97 42.16 (0.62%)

56,916.27 1,020.95 (1.83%)

10,579.52 -29.36 (-0.28%)

92.44 -0.46 (-0.50%)

107.96 0.52 (0.48%)

124.05 0.88 (0.72%)

0.58 0.00 (0.32%)